首页> 美国卫生研究院文献>Materials >Nanoparticles Suitable for BCAA Isolation Can Serve for Use in Magnetic Lipoplex-Based Delivery System for L I V or R-rich Antimicrobial Peptides
【2h】

Nanoparticles Suitable for BCAA Isolation Can Serve for Use in Magnetic Lipoplex-Based Delivery System for L I V or R-rich Antimicrobial Peptides

机译:适用于BCAA分离的纳米颗粒可用于基于脂基复合物的磁性系统用于富含LIV或R的抗菌肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper investigates the synthesis of paramagnetic nanoparticles, which are able to bind branched chain amino acids (BCAAs)—leucine, valine, and isoleucine and, thus, serve as a tool for their isolation. Further, by this, we present an approach for encapsulation of nanoparticles into a liposome cavity resulting in a delivery system. Analyses of valine and leucine in entire complex show that 31.3% and 32.6% recoveries are reached for those amino acids. Evaluation of results shows that the success rate of delivery in Escherichia coli (E. coli) is higher in the case of BCAAs on nanoparticles entrapped in liposomes (28.7% and 34.7% for valine and leucine, respectively) when compared to nanoparticles with no liposomal envelope (18.3% and 13.7% for valine and leucine, respectively). The nanoparticles with no liposomal envelope exhibit the negative zeta potential (−9.1 ± 0.3 mV); however, their encapsulation results in a shift into positive values (range of 28.9 ± 0.4 to 33.1 ± 0.5 mV). Thus, electrostatic interactions with negatively-charged cell membranes (approx. −50 mV in the case of E. coli) leads to a better uptake of cargo. Our delivery system was finally tested with the leucine-rich antimicrobial peptide (FALALKALKKALKKLKKALKKAL) and it is shown that hemocompatibility (7.5%) and antimicrobial activity of the entire complex against E. coli, Staphylococcus aureus (S. aureus), and methicilin-resistant S. aureus (MRSA) is comparable or better than conventional penicillin antibiotics.
机译:本文研究了顺磁性纳米粒子的合成,该纳米粒子能够结合支链氨基酸(BCAA)-亮氨酸,缬氨酸和异亮氨酸,因此可以用作分离它们的工具。此外,通过这种方法,我们提出了一种将纳米颗粒封装到脂质体腔中的方法,从而形成了递送系统。整个复合物中缬氨酸和亮氨酸的分析表明,这些氨基酸的回收率分别达到31.3%和32.6%。结果评估表明,与没有脂质体的纳米颗粒相比,在脂质体中包埋的纳米颗粒上进行BCAA时,大肠杆菌(E. coli)的成功交付率更高(缬氨酸和亮氨酸分别为28.7%和34.7%)。包膜(缬氨酸和亮氨酸分别为18.3%和13.7%)。没有脂质体包膜的纳米颗粒表现出负的ζ电势(-9.1±0.3 mV);然而,它们的封装导致转换为正值(范围为28.9±0.4至33.1±0.5 mV)。因此,与带负电荷的细胞膜(在大肠杆菌中约为-50 mV)的静电相互作用导致更好地吸收货物。我们的递送系统最终用富含亮氨酸的抗菌肽(FALALKALKKALKKLKKALKKAL)进行了测试,结果表明,整个复合物对大肠杆菌,金黄色葡萄球菌(S. aureus)和耐甲氧西林的血液相容性(7.5%)和抗菌活性金黄色葡萄球菌(MRSA)与常规青霉素抗生素相当或更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号